Synthetic growth hormone–releasing hormone analogue studied in endocrine signaling research.
Tesamorelin is a synthetic analogue of growth hormone–releasing hormone (GHRH), designed to activate the GHRH receptor in experimental settings.
The sequence is engineered for stability compared to native GHRH fragments, while preserving receptor binding characteristics.
Referenced in research on hypothalamic–pituitary signaling and growth hormone axis regulation.
Endocrine signaling, peptide hormone receptor research, GH axis pathway studies.